Genetically Targeted Fractionated Chemotherapy
Speaker 1: Thank you for joining me. We're going to be talking about chemotherapy which is the real mainstay of conventional treatment for cancer. Really, if you look at this data here real quick, what comes right at you, chemotherapy success rate is only 2% effective after five years for late stage and advanced cancer. This is Dr. Faguet's work who has written a number of articles and papers and has done research funded by the National Cancer Institute.
It is outstanding when we look at this data. More importantly, what people ask us all the time, why doesn't chemotherapy work, or why does it stop working? Why is chemotherapy disappointing with toxic side effects and poor quality of life and in worst cases causing death? This is in the back of every patient's mind when they contact us. After a decade of helping the most complex cancers, late stage cancers, we have some really exciting news that's going to help you outperform in the area of chemotherapy. It's very important to understand that the current method used like chemotherapy is basically non-specific, too general, very cookbook-like in protocol design.
Let me explain. This gives a poor diagnosis and poor planning which is why we don't see the outcomes we want to see in cancer. The current methods used by cancers in hospitals through the U.S. And Canada is not satisfactory.
It's not sufficient with the current data that we have coming in from around the world. It doesn't provide us the right information we need to shut down the cancer cell growth and spread. Really, that's the bottom line.
Let me give you an example here, a patient diagnosed with cancer. They may have stage 3 adenocarcinoma of the colon or stage 2 ductal carcinoma of the breast. The oncologist will get that information go look up at a book or in a protocol or online wherever their data is and begin the treatment plan and then, monitor the patient whether it's one, two three months later. If it doesn't work, then go back and in and look at a new regimen, a new treatment plan.
Really, that is not the most accurate and detailed way to build a treatment plan. I'll explain this to you in detail as we go through this. The chemotherapy regimens come from oncology groups that have had discussions and pharmaceutical companies that have done studies, but it's too general. Chemotherapy, even in its studies in late stage cancer patients have only extended life three to five months and those are considered sometimes new blockbuster drugs. There's really a lot of improvement here that I'm going to show you we'll be able to do.
Here's the key problem. Cancer treatment being done based on cancer type and staging, that's not enough information. Based on the scientific literature from around the world and what we've seen and in the work that we've done, that this is really important.
Every person's cancer is different. Individual cancer is different, including people with the same types and stages of cancer. Each cancer has its own genetic blueprint that provides the real information to show the vulnerability of the cancer or how to treat it. Each cancer has its own signaling pathways, different receptors, metabolism, molecular profile. Knowing this and treating this impacts the overall outcome of the success of cancer treatment. By receiving the genetic information of each patient's cancer, we're able to unlock the optimal treatments and provide the patient the best treatment option. When you're talking about chemotherapy and unlocking it, this is really important. This will help you.
The problem with the current model of chemotherapy, it's like using one key to try to open up 40 or 50 different variations or doors within the cancer. It's not going to work. It might open up one or two, but not the other. The current pathology reports that are used are not specific enough. They're telling you the type and the staging, but not enough detail that you need, so the one size fits all model doesn't work. This is excellent news for cancer patients because once we have this information unlocked, all kinds of treatment options you didn't know were available before. Let's show you how our process works. It's quite revolutionary.
First, we get the genetic testing done and the information of that specific cancer for that specific patient. That data tells us the critical pathways of unlocking the mechanism of that action that we can use to treat the patient and it unlocks the code for destroying that cancer. The data then matches scientific research and papers available worldwide. It provides us the treatment options that the patient would've never have known about and that is everything. Listen to this. We have found that over 75% of the patients that come to us were on the wrong chemotherapy altogether. They were getting all the side effects, all the negative part but none of the benefits.
They were on the wrong treatment. Not only does the type of chemotherapy we do give you a better selection in the treatment, but it provides also proprietary advance natural treatment that complements and increase the patient's energy, enhances the chemotherapy's effectiveness and boosts overall immunity for the patient. These are treatments that our proprietary methods allow us even to give small, fractionated doses of chemotherapy so that patients have little to no side effects. This is very important, because the side effects can be worse than the treatment.
In our process, that's not the case. We can target the cancer cells and protect the normal, healthy cells of the body. Envita provides additional proprietary treatment to slow down the cancer growth and block the mutation. This is really important.
When people are under chemotherapy, the cancer can mutate and change and become unresponsive. We slow that down so that the chemo can take effect. This is really important because we get calls all the time about patients are afraid of chemotherapy, the side effects, toxicity, they don't want to do it.
This is the good news. With our information, we can use non-chemotherapy, natural methods or the various combinations that you need to help you, with our without. We have the option to do that and still the benefits continue. We can monitor the patient's immune specific response, strengthen, enhance the immune system because the immune system is really the last and first offense against cancer for long term success. Here is the bottom line.
The future of cancer treatment is here. You don't have to wait to be told the treatment didn't work, or hang around in remission wondering if you're going to fall out, if the cancer is going to come back, or embrace a poor diagnosis that was given to you by your doctor. We can help you. Instead, contact Envita today to receive more information on your cancer treatment option. Treatments that are only found at Envita, Envita's processes and treatments that can help you. Changing cancer outcomes has been our work for over a decade. Let us help you.
Contact us to receive more information and we're here and happy to help you.
Cancer Related Fatigue Cancer-related fatigue is one of the most common side effects of cancer and cancer treatment. This type of fatigue is very different than feeling tired from everyday…By: Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute
Speaker 1: Thank you for joining me. We're going to be talking about chemotherapy which is the real mainstay of conventional treatment for cancer. Really, if you look at this data…By: Envita Medical Center
Ty Bollinger: Yeah, so let’s go back in time to the impetus that caused you to write your book. You wrote a book on cancer and it was called—what? Laura Bond: It’s called You Can Say…By: The Truth About Cancer
My name is Aaron Sarver. I got a brain virus about nine months ago. And because I was on maintenance chemo for so long, it actually lowered my immune system and that's how I got…By: Cerebrum Health Centers
Chemotherapy is hard to explain because for everybody it is different. It’s changed for me even. I go home like for a week or a couple of days and I come back and then that’s when Chemo…By: St. Louis Children's Hospital